Aguiar-Lucander described Tarpeyo, its lead drug, as “beautiful, unique, but pretty simple,” adding that it has received accelerated FDA approval for treating IgA nephropathy, an autoimmune kidney ...
Dialysis is a life-sustaining treatment for people who have lost the function of their kidneys. The leading cause of kidney failure is type 2 diabetes. The numbers of people starting dialysis are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results